This reading list we received from Drs entirely disinterested. E. Valstar, (Orthomolecular) doctor / biologist. We provide this list are unchanged for publication. .
Scroll down for list.
Valstar wrote the book Nutritional intervention in cancer, a signal to the conventional oncology. See description on page, etc. ISBN cancer rates. We want to mention that we have no business or substantive ties with Engelbert Valstar, but this book and lists seem to us so interesting that we want to change places. Questions / comments can be sent to the editor: redactie@kanker-actueel.nl We will keep your questions / comments to be forwarded Valstar. Also on this list and further information on this page is of course our disclaimer applies.
More detailed descriptions and other studies see and nutrition research. And we try to at least the abstract and the results of the Phase III trials and pivotal Phase II studies in the literature list and nutrition research. or current mainstream research to publish or not fitted comments.
For regular treatments in general because the only randomized study possible side effects. Moreover, a randomized study of conventional treatments often never implemented. This assertion of Valstar based on relevant literature is in NTvG (see NTvG 136: 709-710, 1992) by the respective oncologists not contradicted.
See also Nutritional Oncology, Heber D. et al ISBN 0-12-335960-0, the book was edited by Harvard and by the Memorial Sloan Kettering Institute! ).
(Editors note: See extensive bibliography in the book of Valstar Nutritional intervention in cancer, a signal to the conventional oncology and now as published on this site)..
To this list are Hans Houtsmuller, Ed Woerlee Johan Bolhuis and important contributions.
Bibliography of studies cancer and nutrition / supplementation. Studies: 401 t / m 500
401) Braga M et al; Infusionsther Transfusionsmed 22: 280-4, 1995, Omega-3 fatty acids, arginine plus RNA reduce the risk of infection in patients operated due to gastric or pancreatic cancer, the length of stay was shorter by supplementation demonstrated.
402) Braga M et al, Eur J Surg 162: 105-12, 1996, in patients who undergo surgery are associated with gastric or pancreatic cancer decreases the combination of omega-3 fatty acids, arginine and RNA has the chance of infection, but the severity of infection and length of stay in hospital.
403) Daly JM et al, Surgery 112: 56-7, 1992, Omega-3 fatty acids, RNA and arginine together shortening the length of stay in hospital patients in the upper part of the gastrointestinal tract surgery, the trend that was further these combined supplementation reduced the number of infections.
404) Heyn RM et al, Blood 46: 431-42, 1975, in children diagnosed with acute lymphoblastic leukemia BCG increases the remission duration after chemotherapy does not.
405) Senkal M et al, Arch Surg 134: 1309-1316, 1999, Omega-3 fatty acids, arginine and RNA reduction in patients to operate due to a tumor in the upper gastrointestinal tract, the risk of infection and treatment costs (the latter with more than half).
406) Braga M et al, Arch Surg 134: 428-33, 1999, Omega-3 fatty acids, arginine and RNA reduction in patients with colon, stomach or pancreatic cancer surgery should be in double-blind randomized study the risk of infection with more than half and shorten the length of stay also demonstrated.
407) Gianotti L et al, Gastroenterology 122: 1763-1770, 2002, both pre-and perioperative supplementation with arginine, omega-3 fatty acids and RNA in patients to operate together to reduce gastrointestinal cancer risk of postoperative infection and hospitalization in hospital. 395-403 and 405-407 from the publications it is clear that the combination of omega-3 fatty acids, arginine and RNA in patients to operate because of a gastrointestinal tumor or a pancreatic cancer, reduces the risk of infection and the length of stay in hospital.
408) JD McCracken et al, Cancer 49: 2252-8, 1982; BCG as a live vaccine in addition to induction chemotherapy for small cell lung cancer after chemotherapy improves if this is the continued survival.
409) Jackson DV et al, Cancer 50: 48-52, 1982; Methanol extract improves the adjuvant treatment after chemo-radiotherapy prognosis kleincelliglongcarcinoom not, combined with 408 provides that, the live vaccine is and the dead methanol extract does not work in small cell lung cancer (live vaccines are generally better), although it is true that BCG should be passed over.
410) Jansen HM et al, Thorax 35: 781-7, 1980, in patients with locally advanced squamous cell carcinoma of the lung (nonsmall cell), which no detectable tumor load anymore BCG improves the prognosis: this was clearly correlated with improved cellular immunity.
411) 2 nd Richards F et al, Cancer 47: 2827-32, 1981, a methanol extract of BCG (BCG vaccine is not true) improves response to chemotherapy and the prognosis of patients with metastatic non-small cell lung cancer is not.
412) AT Mennie et al, Lancet 2 (7942): 942-3, 1975; Buffered aspirin reduces double-blind randomized study of the gastrointestinal side effects of radiation such as increased bowel movement, flatulence and pain.
413) I Fukui et al, Nippon Hinyokika Gakkai Zasshi 83: 1633-9, 1992; In a small randomized trial in approximately 50 bladder cancer patients with OK-432 found no improvement in survival, combining this research with similar studies and 234.254 255 does provide, that OK-432 for bladder cancer improves disease-free survival.
414) Watanabe Y et al; Gan To Kagaku Ryoho 12: 21-35, 1985, OK-432 improves the prognosis of patients randomized study, which potentially curative surgery for lung cancer and additional chemotherapy.
415) E Hellstrom et al, Eur J Hematol 45: 255-61, 1990; The combination of 13-cis-retinoic acid and 1-alpha-hydroxy vitamin D3 improves randomized trial in 63 patients with MDS, with low doses ARA-C treatment, the remission probability, duration and survival is not, it seems that the progression to more malignant myeloid leukemia are inhibited (P = 0.0527 one-sided). Combined with the fact that 102 of the reference list has been found that vitamin D is the progression of MDS to myeloid leukemia inhibits vitamin D makes me basically in MDS recommend. In issue 386 with cis-retinoic acid, even in MDS patients found a lower mortality, in 387 was 13-cis-retinoic acid at a follow-up of 6 months no effect on the progression of MDS were found. My final conclusion is that the combination of this form of vitamin D and 13-cisretinoinezuur at least the benefit of the doubt.
416) Goebell PJ et al, J Urology 168: 72-5, 2002; Mistletoe reduces the risk of recurrence in bladder cancer at an early stage and almost certainly not significant, although there seem to be fewer multiple relapses by the mistletoe to act, but this is not significant, study in a larger number of patients is indicated (here, there were only 45 patients in total), see also numbers 79, 97, 144 and 372.
417) E la Cour Petersen et al, Cancer Immunol Immunother 16: 88-92, 1983, Corynebacterium parvum by chemotherapy prolongs remission duration in patients with myeloid leukemia is not significant, however, life in the Corynebacterium parvum group opposed to what the authors believe be significantly extended (4-6 months).
418) Zemskov V et al, Arch Surg 387 Beck's Long: 84-89, 2002, Ukrain improves randomized double-blind study, the Karnofsky index in patients with pancreatic cancer and reduces mortality after one year.
419) KB Menander-Huber et al, Urol Res 6: 255-7, 1978, Copper-Zinc-superoxidedismutase reduces randomized, double-blind study, the effects of irradiation of the bladder, the bladder and bowel, without the therapeutic effect of interfering radiation.
420) Vokes EE et al, Br J Cancer 62: 1015-1017, 1990, a continuous infusion of magnesium and hypomagnesemia symptoms are correspondingly due to cisplatin efficiently than magnesium as indicated.
421) MS Ansari and NP Gupta, BJU Int 92: 375-8, 2003, in patients with prostate cancer who have undergone a orchectomie enhances lycopene and the reduction in PSA by lycopene is also correspondingly lower mortality.
xxx) hoerni B et al, Br J Hematol 71: 161-3, with longer follow-up reference 390 indicates that the survival BCG seconds after over 11 years is much better: just 60 instead of 30%.
422) Benner SE, et all, JNCI 86: p. 40-1, 1994, 13-cis-retinoic acid reduces the risk of throat cancer after treatment is not significant, but it reduces the number of new primary tumors, it must be an early therapeutic effect based.
423) Gall S et al, Gynecol Oncol 25 :26-36, 1986, Corynebacterium parvum plus melphalan is ovarian cancer patients as adjuvant strategy no better than melphalan alone.
424) Fulimora T et al, World J Surg 18: 150-5, 1994: Rinsing the abdominal cavity with hyperthermic water solution compared to a control group at least as effective in improving survival after surgery for gastric cancer and rinse with a standard other economic solution with mitomycin C and cisplatin.
425) AE Morgan et al, Seminars in Oncology 9: 71-4, NAC reduced in patients with lung cancer which ifosfamide heamturie received significantly associated with cystitis.
426) Myers C et al, Seminars in Oncology 10: 53-55, 1983, NAC is reduced ejection fraction heart against adriamycin, with extra high doses of adriamycin that NAC has no more effect in this study, may be at higher doses of NAC or with another mode of administration of NAC.
427) Wang I, et al, Br J Dermatol 144: 832-40, 2001; PDT plus delta-aminolevulinic acid (ALA) is as good as cryosurgery to treat basal cell carcinomas, in this randomized study was shorter healing time and cosmetic result with PDT plus ALA significantly better.
428) A. Maier et al, Lasers Surg Med 26: 308-15, 2000, Oxygen improves outcome in metastatic PDT oesophagus-/maagkanker: there was more oxygen to tumors and significantly greater decline in life extension (an extra five months).
429) U.S. Cheng et al, Cancer 49: 239-44, 1982; Corynebacterium parvum enhances the result of throat cancer is not related to radiation, it was at 28 versus 29 patients, so the disease-free survival very much should change in order to reach significance; says no difference in this case produces very little.
430) Fearon KC et al, Gut 52: 1479-1486, 2003, Omega-3 fatty acids plus antioxidants to patients with advanced cancer in a randomized double-blind study caxechie against, was also better than the quality of life.
431) Van der Zee J et al, Lancet 355: 1119-1125, 2000; hyperthermia radiotherapy improves local control of advanced pelvic tumors, further analysis showed that rectal no benefit could be achieved with hyperthermia for bladder cancer and that this very temporary was, was very marked benefit for patients with hyperthermia al baarmoederhalskanker.Overigens called Hippocrates
432) NO Datta et al, Indian Med Gazette 121: 68-71, 1987. Hyperthermia radiotherapy improves disease-free survival in cases of stage 3B cervixcarcinoompatienten which undergo radiotherapy.
433) Overgaard J et al, Int J Hyperthermia 12: 3-20, 1996, Hyperthermia enhances the response to radiation risk of melanoma significantly in randomized studies, hyperthermia was also associated with longer life expectancy.
434) International Collaborative Hyperthermia Group, Int J Radiation Oncology Biol Phys 35: 731-44, 1996, the case of advanced local breast cancer, or a local recurrent breast cancer, local hyperthermia to radiotherapy response likely to increase, the apparent local survival (!) hyperthermia, however, as might be expected to have no influence.
435) Alimi D et al, J Clin Oncology 21: 4120-6, 2003, ear acupuncture reduces a randomized double-blind study chronic pain in cancer patients significantly.
436) Petrelli NJ et al, Adv Exp Med Biol 244: 143-55, 1988, also from this study showed that 5-FU plus leucovorin for metastatic colorectal cancer is more effective than 5-FU alone.
437) Colombo R et al, J Clin Oncol 21: 4270-6, 2003, Hyperthermia significantly improves the outcome of chemotherapy flushing of the bladder, ie it lowers the risk of recurrence further, according to a randomized trial.
438) Raffoux E, J Clin Oncol 21: 2326-34, 2003, Arsenic trioxide is effective in patients with relapsed promyelocytic leukemia, but improves the response rate is not atra.
439) A. Lipton et al, J Med 13: 419-29, 1982; Aspirin appears in a small randomized study the risk of recurrence of colon cancer is not reduced.
440) Agter Esch J et al, Anticancer Drugs 14: 639-44, 2003; ATP shown in randomized studies in lung cancer patients stage 3B where the weight of prolonging life.
441) Falk RE et al, Can Med Assoc J 128: 1385-8, 1983; intraperitoneal administered BCG improves survival of patients with gastric, colon and pancreatic cancer are not, oral administration of BCG to patients with operable cancer improved survival However, randomized study.
442) Monz BU et al, Pharmacoeconomics 21: 709-19, 2003, folinic acid, 5-FU improves outcome in metastatic colorectal cancer even if already given to levamisole ie disease-free survival and improve the survival sec.
443) Net N Rodrigues Jr. et al, Arch Esp Urol 32: 417-26, 1979; Also oral administration of BCG after surgery for superficial bladder cancer reduces the risk of recurrence in randomized studies, oral BCG is much less stressful and much cheaper then rinse with BCG .
444) Haghbin M et al, Cancer 46: 2577-86, 1980; BCG decreases in young children with acute lymphoblastic leukemia in long-term immunosuppression, an effect on the risk of recurrence was not testable because the risk of recurrence is low and small groups ( 20 patients) concerned.
445) Lamm DL et al, J Urol 124: 38-40, 1980, intravesical BCG therapy decreases recurrence rates after local treatment for bladder cancer.
446) Fenaux P, Leukemia 8S3: S70-2, 1994, Atra improves remission in randomized studies with chemotherapy in promyelocytic leukemia risk.
447) JA Whittaker et al, Br J Haematol 45 :389-400, 1980, BCG intravenously improves survival of patients with acute myeloid leukemia successfully treated with chemotherapy.
448) Tallman MS et al, Blood 100: 4298-302; Atra improves randomized study the long-term prognosis of promyelocytic obvious.
449) Estey EH et al, Blood 93: 2478-84, 1999; Atra improves treatment outcomes in randomized studies of MDS and acute myeloid leukemia is not.
450) Lamm DL et al, Cancer 48 :82-8, 1981; In this randomized study enhances BCG in patients treated for superficial bladder cancer disease-free survival.
451) Pouillart P et al, Bull Cancer 68: 6-18, 1981; BCG addition to chemotherapy in metastatic breast cancer improves the prognosis is not.
452) Pouillart P et al, Bull Cancer 68 :171-86, 1981, BCG is not important in breast cancer in adjuvantsituatie.
453) Winters WD, Lamm DL, Cancer Res 41: 2672-6, 1981, also here in a small study of bladder cancer recurrences less by rinses with BCG, the result is only significant in combination with other similar studies.
454) Stryckman PA et al, Blood 62 :606-15, 1983, in patients with acute lymphoblastic leukemia found by maintenance chemotherapy after complete remission, a better disease-free survival than with BCG as maintenance therapy, the survival was however similar, significant was the finding that patients on maintenance immunotherapy responded better to chemotherapy after a relapse than those who received maintenance chemotherapy, such that the maintenance of survival than if it was longer than immunotherapy.
455) Glick JH et al, Cancer Treatment Reports 66: 855-70, 1982; In Hodgkin's disease after successful BCG intensive chemotherapy has no effect on the prognosis (as opposed to the Non-Hodgkin's disease).
456) JH Xing et al, Zhongguo Zhong Xi Yi Jie He Za Zhi 21: 260-1, 2001; Ginseng shown in randomized studies by apoptosis induction and clinical symptoms of rectal cancer significantly reduced, see reference 214.
457) Ertekin MV et al, Int J Oncol Biol Phys Radiate 58: 167-74, 2004, Zinc supplementation reduces double-blind randomized study mucositis and oral discomfort "because of throat cancer in patients who are irradiated.
458) Kamat MR et al, J Urol 152 :1424-8, 1994; This randomized study shows that BCG instillation of bladder cancer the risk of recurrence after treatment of superficial bladder cancer decreases.
459) Kaushal V et al, Int J Tissue React 23: 105-10, 2001, in a randomized study shows placenta extract the risk and severity of mucositis due to radiation therapy for throat cancer very significantly reduce.
460) Jacquillat C et al, Recent Results Cancer Research 80: 254-8, 1982, Corynebacterium parvum and BCG immunotherapy in addition to intensive chemotherapy as an adjuvant in the treatment of malignant melanoma seems to result in long-term improvement. But see also references 382-385.
461) Cheng JH et al, Zhongguo Zhong Xi Yi Jie He Za Zhi 21: 165-7, 2001; infusion of turmeric oil along with Chinese herbs randomized study extends the lives of patients with primary liver cancer significantly compared with chemoembolisatie.
462) Noyes R et al, J Clin Pharmacol 15: 139-43, 1975; Tetrahydrocannibol (THC) is dose-dependent in cancer patients compared to placebo analgesic.
463) Orr and LE Mckernan JF; J Clin Pharmacol 21: 76S-80S, 1981, THC is nausea in patients receiving FAC regimen will not only better than placebo but also against more than prochlorperazine.
464) Chang AE et al, Ann Intern Med 91: 819-24, 1979; In this randomized study shows THC nausea and vomiting associated with chemotherapy such as methotrexate significantly reduced.
465) Sallan SE, et al, New Engl J Med 302: 135-8, 1980; In this randomized double-blind crossover study found THC was significantly better effective against nausea and vomiting associated with chemotherapy, or regular medication.
466) Lane M et al, Am J Clin Oncol 13: 480-4, 1990; In this randomized study of THC significantly reduces nausea and vomiting due to placebo or standard treatment.
467) Frytak S et al, Ann Intern Med 91: 825-30, 1979, THC reduces cancer patients who receive chemotherapy nausea and vomiting better than placebo but not better than conventional treatment. Well more like drowsiness by THC.
468) JT Unger Leader, Cancer 50: 636-45, 1982; THC reduces nausea caused by chemotherapy in cancer patients as well as regular medication.
469) KW Tsang et al, Respir Med 97: 618-24, 2003, PSP, PSK as an ingredient of mushroom Kawaratake, slows the progression of large cell lung cancer randomized study significantly.
470) Suh SO et al, Am J Chin Med 30: 483-94, 2002; Meyer Panax ginseng increases as additional adjuvant chemo for stomach cancer patients operated on the 5-year survival significantly.
471) Li Z et al; Hua Xi Yi Ke Da Xue Xue Bao 31: 334-7, 2000, Vaccination for Pseudomonas aeruginosa improves immunity in cancer patients so much that at least in randomized studies 2 / 3 of the infections associated with chemotherapy are particularly occur, which improves the quality of life and better treatment possible.
472) Loprinzi CL et al, N Engl J Med 340: 346-50, 1999; In this randomized study with coumarin only a non-significant reduction of lymph edema associated with treated breast cancer, in references 325 and 326, the effect of coumarin was significantly beneficial in this regard, a preliminary meta-analysis shows that coumarin lymph edema of the arm associated with treatment for breast cancer reduces.
473) Nakamura H et al, Acta Haematol 46 jpn :1087-92, 1983, Nocardia rubra improves survival of patients successfully treated for acute myeloid leukemia in an absolute sense, but nevertheless significant in terms of trend, Nocardia rubra is therefore useful in such patients , see also reference 93 with similar results.
474) Ogura T, Sakatani M, Nihon Kyobu Shikkan Gakkai Zasshi 23: 62-7, 1985; Nocardia extract prolongs the life of patients with small cell lung cancer significantly, see the many other publications on this list Nocardia.
475) Kikuchi K, Takahashi N, Gan To Kagaku Ryoho 12: 1476-1481, 1985: OK-432 enhances the survival of relapsed / well advanced breast cancer in a pilot study as not significant.
476) K. Ito et al, Int J Colorectal Dis 19 :157-64, 2003, PSK decreases as additional adjuvant in patients who had stage C colon cancer mortality in randomized trial.
477) Ohwada S et al, Dis Colon Rectum 46: 1060-8, 2003, PSK improves survival of patients with colorectal cancer who have had surgery and adjuvant chemotherapy given.
478) Nakazawa S et al, Scand J Gastroenterol 23: 539-45, 1988, OK-432 prolongs life in randomized studies of patients with advanced gastric cancer.
479) Schilling J et al, Nutrition 12: 423-9, 1996, Omega-3 fatty acids, RNA and L-arginine improves the immunity of post-operative patients are operated on their belly and reduce the risk of postoperative infection.
480) Bower RH et al, Crit Care Med 23: 436-9, omega-3 fatty acids, RNA and L-arginine to reduce (cancer) surgery to the stomach the risk of infection and shorten the length of stay in hospital, see the many other Studies in this list with a similar conclusion.
481) Kanab S et al; Gan No Rinsho 31: 1805-9, 1985, the combination of PSK and OK-432 demonstrated improved median survival of gastric cancer patients stage 4.
482) Imaizumi M et al; Gan To Kagaku Ryoho 17 :2397-403, 1990, the combination of PSK and OK-432 in addition adjuvantchemo in theory curatively operated gastric cancer patients improves 5 - and 10-year survival is not significant, a meta- analysis shows, however, PSK and OK-432 in this a significantly better survival: Kim R et al, Anticancer Res 22 (1A): 283-9, 2002.
483) Guinan PD et al, Am J Clin Oncol 5: 65-8, 1982: BCG prolongs life in randomized studies of prostate cancer patients stage D.
484) P Guinan et al, Urology 20: 401-3, 1982; BCG also prolongs the life of this randomized study of prostate cancer patients stage D.
485) Cerea G et al, Anticancer Res 23: 1951-4, 2003, Melatonin improves in patients with metastatic colorectal cancer treated with irinotecan and significant disease control.
486) Vogl SE, et al, Cancer 50 :2295-300, 1982, Corynebacterium parvum Subcutaneous injections improves methotrexate results in randomized studies in metastatic throat cancer in randomized trials.
487) Kosaka A et al; Gan To Kagaku Ryoho, 14: 516-22, 1987, in randomized studies lentinan potentiates hormonal therapy for breast cancer.
488) Lissoni P et al, J Pineal Res 35 :12-5, 2003, Melatonin reduces the side effects of chemotherapy for lung cancer, and improves the chance of regression to now show the long-term survival.
489) Lissoni P et al, Neuroendocrinol Lett 24 :83-5, 2003, 5-methoxytryptamine reduces randomized study anemia as a side effect of cisplatin.
490) M Cazacu et al, Cancer Biother Radio Pharma 18 :27-34, 2003, Isorel, a mistletoe extract improves median survival of Dukes C colon cancer patients following surgery and receive chemotherapy.
491) Barton DL et al, J Clin Oncol 16 :495-500, 1998, Vitamin E reduces randomized double-blind study hot flashes in breast cancer patients.
492) Wiernik PH et al, Cancer Invest 10: 1-9, 1992, Vitamin B6 reduces randomized study of the neurotoxicity of cisplatin in patients with ovarian cancer, but shorten the duration of response.
493) Jurincic CD et al, J Urol 139: 723-6, 1988; An extract prevents recurrence of bladder cancer hemocyanin effective than mitomycin C, according to a randomized trial.
494) Beusterien KM et al, Support Care Cancer 11: 304-12, 2003; next Histamine enhances interleukin-2 in patients with metastatic melanoma, the median time in which there is a good quality of life significantly compared with interleukin-2 alone, as according to this randomized study.
495) Kalble T et al; Urologists A. 33 :133-7, 1994, BCG prevents local recurrence of bladder cancer was significantly better than interferon A, according to a randomized trial.
496) Kalble T et al; Urologists A. 30: 118-21, 1991; BCG prevents lokaalrecidieven of bladder cancer again significantly better than an extract with hemocyanin.
497) Jurincic CD-Winkler et al, Wien Klin Wochenschr 106: 455-8, 1994, an extract with hemocyanin as adjuvant randomized study no significant beneficial effect on the course of kidney cancer after surgery.
498) Skulchan V et al, J Med Assoc Thai 72: 506-8, 1989; Inosine (plays a role in ATP synthesis) reduces randomized study breast cancer because of radiation leukopenia.
499) Anonymous, Lancet 355: 1588-1596, 2000, The adjuvantsituatie is 5-FU in colorectal cancer as well as low high-dose leucovorin.
500) Tice JA et al, JAMA 290: 207-14, 2003, with higher doses of isoflavones are not only less expensive hot flashes be shorter, according to a randomized double-blind study.
For further studies following link.
